For example, the report found that for males the rate of new prescriptions per 100 000 people for lipid-lowering drugs was 286 in metropolitan areas, 147 in rural areas and 10 in remote areas. 1 Mortality rates for coronary heart disease are higher outside capital cities. The difference between rural and urban areas accounts for approximately 5000 excess deaths per year. 2 If some of the increased mortality in rural people 1, 3 is the result of underprescribing for cardiovascular disease, then doctors can make a difference by addressing the issue of appropriate prescribing and 'compliance'.
Access problems probably account for much of the rural-urban gap. We know that rural patients see their general practitioners, on average, 1-2 fewer times per year than city dwellers. 1, 4 Additionally, rural patients have less access to cardiologists, who are more likely to be aggressive with cardiac therapies and do not have to pay attention to the patient's many other needs. Timely access to technical intervention in acute coronary syndromes is a problem, for example if patients have to travel for hours before even being considered for thrombolytics, pacemakers or percutaneous coronary intervention.
The evidence about prevention and treatment of ischaemic heart disease has matured to the point that guidelines are relatively simple and straightforward for most patients. 1 While specialists may be more familiar with guidelines, the studies about whether or not patients with cardiovascular disease are best cared for by cardiologists, general physicians or general practitioners are conflicting. Some studies show more intervention by specialists, but no difference in mortality. Others show that patients do better if cared for by cardiologists, or doctors who graduated from medical school more recently, possibly because they have been trained to use guidelines. 5 Even if doctors know the recommended drugs, they may be reluctant to prescribe them. For example, doctors often hesitate to prescribe beta blockers because of myths about suppression of hypoglycaemic reactions in diabetes. 6 However, patients with diabetes and cardiovascular disease benefit (reduced mortality) more than others from beta blockers so the drugs are strongly recommended. 1, 6 Chronic obstructive pulmonary disease often raises concerns among doctors when beta blockers are indicated, but systematic reviews show that this concern should not prevent doctors from prescribing this life-saving therapy. 7 Rural areas have a disproportionately high and increasing Diabetes is also associated with restless legs syndrome. Dominic Thyagarajan explains how people can be helped without the need to take neurological drugs.
